Nasdaq20d
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
Cervical discogenic pain syndrome is a common ... The commonly affected levels are C5/C6 and C6/C7, with C7 being the most common nerve root involved. Initially, the symptoms present proximally ...
Nasdaq20d
BioRestorative Therapies, Inc. Receives FDA IND Clearance for BRTX-100 to Treat Chronic Cervical Discogenic Pain
Cervical discogenic pain syndrome is a common ... The commonly affected levels are C5/C6 and C6/C7, with C7 being the most common nerve root involved. Initially, the symptoms present proximally ...